Parallel Advisors, LLC Gilead Sciences, Inc. Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 39,298 shares of GILD stock, worth $3.54 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

39,298

Previous 58,123 32.39%

Holding current value

$3.54 Million

Previous $3.99 Million 17.41%

% of portfolio

0.08%

Previous 0.1%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $1.25 Million - $1.58 Million	-18,825 Reduced 32.39%	39,298 $3.29 Million
Q2 2024 Aug 08, 2024	BUY	$63.15 - $72.88 $779,839 - $899,995	12,349 Added 26.98%	58,123 $3.99 Million
Q1 2024 May 06, 2024	BUY	$71.58 - $87.29 $174,512 - $212,813	2,438 Added 5.63%	45,774 $3.35 Million
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $15,166 - $17,199	207 Added 0.48%	43,336 $3.51 Million
Q3 2023 May 20, 2024	SELL	$73.94 - $80.67 $105,068 - $114,632	-1,421 Reduced 3.19%	43,129 $3.23 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $105,068 - $114,632	-1,421 Reduced 3.19%	43,129 $3.23 Million
Q2 2023 May 20, 2024	BUY	$76.01 - $86.7 $30,708 - $35,026	404 Added 0.92%	44,550 $3.43 Million
Q2 2023 Aug 04, 2023	BUY	$76.01 - $86.7 $30,708 - $35,026	404 Added 0.92%	44,550 $3.43 Million
Q1 2023 May 20, 2024	SELL	$77.31 - $88.08 $125,860 - $143,394	-1,628 Reduced 3.56%	44,146 $3.66 Million
Q1 2023 Apr 25, 2023	BUY	$77.31 - $88.08 $147,507 - $168,056	1,908 Added 4.52%	44,146 $3.66 Million
Q4 2022 Feb 03, 2023	SELL	$62.32 - $89.47 $148,882 - $213,743	-2,389 Reduced 5.35%	42,238 $3.63 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $457,267 - $522,316	7,680 Added 20.79%	44,627 $2.75 Million
Q2 2022 Aug 01, 2022	BUY	$57.72 - $65.01 $85,887 - $96,734	1,488 Added 4.2%	36,947 $2.28 Million
Q1 2022 Apr 28, 2022	BUY	$57.92 - $72.58 $127,713 - $160,038	2,205 Added 6.63%	35,459 $2.12 Million
Q4 2021 Jan 20, 2022	BUY	$64.88 - $73.64 $146,304 - $166,058	2,255 Added 7.27%	33,254 $2.42 Million
Q3 2021 Nov 02, 2021	BUY	$67.69 - $73.03 $112,162 - $121,010	1,657 Added 5.65%	30,999 $2.17 Million
Q2 2021 Aug 06, 2021	BUY	$63.47 - $69.35 $148,202 - $161,932	2,335 Added 8.65%	29,342 $2.02 Million
Q1 2021 Apr 23, 2021	BUY	$60.0 - $68.46 $49,260 - $56,205	821 Added 3.14%	27,007 $1.75 Million
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $25,492 - $29,047	-450 Reduced 1.69%	26,186 $1.53 Million
Q3 2020 Oct 27, 2020	SELL	$62.1 - $78.08 $111,842 - $140,622	-1,801 Reduced 6.33%	26,636 $1.68 Million
Q2 2020 Jul 16, 2020	BUY	$72.34 - $84.0 $26,259 - $30,492	363 Added 1.29%	28,437 $2.19 Million
Q1 2020 Apr 27, 2020	BUY	$62.63 - $80.22 $188,203 - $241,061	3,005 Added 11.99%	28,074 $2.1 Million
Q4 2019 Jan 30, 2020	SELL	$61.62 - $67.78 $78,627 - $86,487	-1,276 Reduced 4.84%	25,069 $1.63 Million
Q3 2019 Nov 01, 2019	BUY	$62.51 - $69.0 $9,376 - $10,350	150 Added 0.57%	26,345 $1.67 Million
Q2 2019 Aug 05, 2019	BUY	$61.87 - $69.38 $37,555 - $42,113	607 Added 2.37%	26,195 $1.77 Million
Q1 2019 May 01, 2019	SELL	$62.53 - $70.05 $7,253 - $8,125	-116 Reduced 0.45%	25,588 $1.66 Million
Q4 2018 Feb 05, 2019	SELL	$60.54 - $79.0 $371,594 - $484,902	-6,138 Reduced 19.28%	25,704 $1.61 Million
Q3 2018 Nov 01, 2018	BUY	$71.28 - $78.92 $1.85 Million - $2.04 Million	25,900 Added 435.88%	31,842 $2.46 Million
Q2 2018 Jul 30, 2018	SELL	$64.88 - $75.68 $76,104 - $88,772	-1,173 Reduced 16.49%	5,942 $420,000
Q1 2018 May 08, 2018	SELL	$72.84 - $88.8 $12,965 - $15,806	-178 Reduced 2.44%	7,115 $536,000
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $14,799 - $17,372	208 Added 2.94%	7,293 $522,000
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $510,899 - $605,554	7,085 New	7,085 $516,000
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $500,299 - $592,990	-6,938 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	6,938	6,938 $528,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Gilead Sciences, Inc. Transaction History